These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 24906559
1. Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab. Hakozaki M, Tajino T, Yamada H, Hasegawa O, Tasaki K, Watanabe K, Konno S. Diagn Pathol; 2014 Jun 07; 9():111. PubMed ID: 24906559 [Abstract] [Full Text] [Related]
2. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
3. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab. Aponte-Tinao LA, Piuzzi NS, Roitman P, Farfalli GL. Clin Orthop Relat Res; 2015 Sep 08; 473(9):3050-5. PubMed ID: 25758379 [Abstract] [Full Text] [Related]
4. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls. Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA. Hum Pathol; 2017 May 08; 63():89-97. PubMed ID: 28235628 [Abstract] [Full Text] [Related]
5. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May 08; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
6. Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report. van der Heijden L, van de Sande MA, Hogendoorn PC, Gelderblom H, Dijkstra PD. Acta Orthop; 2015 Jun 08; 86(3):393-5. PubMed ID: 25684041 [No Abstract] [Full Text] [Related]
7. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May 08; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
8. An eggshell-like mineralized recurrent lesion in the popliteal region after treatment of giant cell tumor of the bone with denosumab. Akaike K, Suehara Y, Takagi T, Kaneko K, Saito T. Skeletal Radiol; 2014 Dec 08; 43(12):1767-72. PubMed ID: 25052539 [Abstract] [Full Text] [Related]
9. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report. Watanabe N, Matsumoto S, Shimoji T, Ae K, Tanizawa T, Gokita T, Motoi N, Ueno T, Koizumi M. BMC Res Notes; 2014 Sep 05; 7():608. PubMed ID: 25193435 [Abstract] [Full Text] [Related]
16. Denosumab: a new treatment option for giant cell tumor of bone. Lewin J, Thomas D. Drugs Today (Barc); 2013 Nov 05; 49(11):693-700. PubMed ID: 24308016 [Abstract] [Full Text] [Related]
17. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O'Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA. World J Surg Oncol; 2018 Sep 19; 16(1):191. PubMed ID: 30231890 [Abstract] [Full Text] [Related]